Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 4Leukemia, Myeloid, Acute 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Rhabdoid Tumor 1Recurrence 1Primary Myelofibrosis 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Graft vs Host Disease 1Glioma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Congenital Abnormalities 1Choroid Plexus Carcinoma 1Carcinoma, Hepatocellular 1

Interventions

fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Prednisone 1Mycophenolic Acid 1Mesna 1Filgrastim 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Fibrolamellar hepatocellular carcinoma × Antilymphocyte Serum × Clear all
NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡